2Albers GW. Role of ticlopidine for prevention of stroke [J].Stroke, 1992,23(6):912-916.
3lto MK, Smith AR, Lee ML. Ticlopidine:a new platelet aggregation inhibitor [J]. ClinicalPharrnacy,1992,11(7):603-617.
4Joseph R, Han E, Grunfeld S,et al. Effect of tielopidine and Aspirin on platelet ionized calcium in ischemic stroke[J]. Stroke,1991,22(4) :532-533.
5Hershey LA.Stroke Prevention in women:role of aspirin versus ticlopidine [J].Am J Med, 1991,91(3):288-292.
6Hass WK, Easton JD,Adamas HP Jr,et al. A randomized trial comparing ticlopine hydrocholoride with aspirin for the prevention of stroke in highrisk patients [J]. New Engl J Meal,1989,321:501-507.
7Balsano F. Antiplatelet treat ment with liclopidine in unstable angina: a control muhicenter clin ical trial[J]. Circulation, 1990,82:17.
8Schomig A, Newmann FJ, Katrati A, et al. A randomized comparison of antiplatelet of coronary-artery stents [J].New Engl J Med, 1996,334(17):1084-1089.
9Boissel JP. Is it possible to reduce the risk of cardiovasular events in subjects suffering from intermittent claudication of the lower limbs? [J] Thromb Haemostasis,1989,62:681.